1 Year Absolute Returns
-
NAV (₹) on 20 Aug 2026
21.51
1 Day NAV Change
0.24%
Risk Level
Very High Risk
Rating
-
Mirae Asset Nifty 500 Healthcare ETF is a Equity mutual fund categorized under ETF, offered by Mirae Asset Global Investments (India) Pvt. Ltd.. Launched on 27 Jan 2026, investors can start with a ... Read more
AUM
₹ 13.99 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 75.93% |
| Hospitals & Medical Services | 23.01% |
| Medical Equipment & Accessories | 0.47% |
| Services - Others | 0.38% |
| Net Receivables/(Payables) | 0.16% |
| Treps/Reverse Repo | 0.03% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.06% | ₹ 1.41 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.36% | ₹ 1.03 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.63% | ₹ 0.93 | Hospitals & Medical Services |
| Cipla Ltd. | 5.96% | ₹ 0.83 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 5.88% | ₹ 0.82 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 5.40% | ₹ 0.76 | Pharmaceuticals |
| Laurus Labs Ltd. | 5.08% | ₹ 0.71 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 5.03% | ₹ 0.70 | Pharmaceuticals |
| Lupin Ltd. | 4.22% | ₹ 0.59 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.54% | ₹ 0.50 | Hospitals & Medical Services |
| Aurobindo Pharma Ltd. | 3.14% | ₹ 0.44 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.42% | ₹ 0.34 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 2.42% | ₹ 0.34 | Pharmaceuticals |
| Biocon Ltd. | 2.18% | ₹ 0.31 | Pharmaceuticals |
| Zydus Lifesciences Ltd. | 2.03% | ₹ 0.28 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.01% | ₹ 0.28 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 1.74% | ₹ 0.24 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 1.50% | ₹ 0.21 | Hospitals & Medical Services |
| Aster DM Quality Care Ltd. | 1.50% | ₹ 0.21 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 1.43% | ₹ 0.20 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 1.30% | ₹ 0.18 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 1.17% | ₹ 0.16 | Pharmaceuticals |
| Acutaas Chemicals Ltd. | 1.16% | ₹ 0.16 | Pharmaceuticals |
| Wockhardt Ltd. | 1.16% | ₹ 0.16 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 1.07% | ₹ 0.15 | Hospitals & Medical Services |
| Ajanta Pharma Ltd. | 1.05% | ₹ 0.15 | Pharmaceuticals |
| Abbott India Ltd. | 1.03% | ₹ 0.14 | Pharmaceuticals |
| Narayana Hrudayalaya Ltd. | 1.01% | ₹ 0.14 | Hospitals & Medical Services |
| Onesource Specialty Pharma Ltd. | 0.92% | ₹ 0.13 | Pharmaceuticals |
| Piramal Pharma Ltd. | 0.87% | ₹ 0.12 | Pharmaceuticals |
| Global Health Ltd. | 0.86% | ₹ 0.12 | Hospitals & Medical Services |
| Granules India Ltd. | 0.86% | ₹ 0.12 | Pharmaceuticals |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.79% | ₹ 0.11 | Pharmaceuticals |
| Natco Pharma Ltd. | 0.59% | ₹ 0.08 | Pharmaceuticals |
| Rainbow Children's Medicare Ltd. | 0.55% | ₹ 0.08 | Hospitals & Medical Services |
| Jubilant Pharmova Ltd. | 0.54% | ₹ 0.08 | Pharmaceuticals |
| Syngene International Ltd. | 0.53% | ₹ 0.07 | Pharmaceuticals |
| Eris Lifesciences Ltd. | 0.53% | ₹ 0.07 | Pharmaceuticals |
| Pfizer Ltd. | 0.52% | ₹ 0.07 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 0.52% | ₹ 0.07 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 0.50% | ₹ 0.07 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd. | 0.48% | ₹ 0.07 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd. | 0.47% | ₹ 0.07 | Hospitals & Medical Services |
| Polymedicure Ltd. | 0.47% | ₹ 0.07 | Medical Equipment & Accessories |
| Indegene Ltd. | 0.38% | ₹ 0.05 | Services - Others |
| Caplin Point Laboratories Ltd. | 0.36% | ₹ 0.05 | Pharmaceuticals |
| Concord Biotech Ltd. | 0.34% | ₹ 0.05 | Pharmaceuticals |
| Blue Jet Healthcare Ltd. | 0.23% | ₹ 0.03 | Pharmaceuticals |
| Net Receivables / (Payables) | 0.16% | ₹ 0.02 | Others |
| TREPS | 0.03% | ₹ 0 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | - | - | - | - |
| Category returns | 1.34% | 5.65% | 4.57% | 22.22% |
The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty 500 Healthcare Total Return Index, subject to tracking error. ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Silver ETF
ETF
Regular
|
₹225.65 | 110.40% | 228.78% | 0.00% | ₹7,473 | 0.50% |
Very High
|
|
Aditya Birla Sun Life Silver ETF
ETF
Regular
|
₹235.65 | 111.43% | 227.48% | 0.00% | ₹2,756 | 0.35% |
Very High
|
|
ICICI Prudential Silver ETF
ETF
Regular
|
₹235.62 | 111.63% | 226.88% | 0.00% | ₹13,701 | 0.40% |
Very High
|
|
Axis Silver ETF
ETF
Regular
|
₹234.54 | 110.90% | 226.71% | 0.00% | ₹1,855 | 0.42% |
Very High
|
|
Kotak Silver ETF
ETF
Regular
|
₹22.90 | 111.30% | 225.93% | 0.00% | ₹3,376 | 0.35% |
Very High
|
|
DSP Silver ETF
ETF
Regular
|
₹227.59 | 111.51% | 225.88% | 0.00% | ₹1,401 | N/A |
Very High
|
|
Mirae Asset Silver ETF
ETF
Regular
|
₹229.67 | 110.90% | 225.20% | 0.00% | ₹1,102 | 0.36% |
Very High
|
|
Nippon India Silver ETF
ETF
Regular
|
₹225.68 | 110.79% | 224.09% | 0.00% | ₹29,499 | N/A |
Very High
|
|
UTI Silver Exchange Traded Fund
ETF
Regular
|
₹227.82 | 109.73% | 220.86% | 0.00% | ₹1,358 | 0.59% |
Very High
|
|
Mirae Asset NYSE FANG + ETF
ETF
Regular
|
₹171.56 | 32.90% | 184.37% | 232.14% | ₹3,992 | 0.67% |
Very High
|
What is the current NAV of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
What is the fund size (AUM) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
What are the historical returns of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
What is the risk level of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
What is the minimum investment amount for Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article